We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » House Subcommittee Considers Bipartisan Bills on Drug Exclusivity, Safety
House Subcommittee Considers Bipartisan Bills on Drug Exclusivity, Safety
A House subcommittee took up four bipartisan drug bills yesterday, including one — introduced in October — that would close a loophole in the FDA’s orphan drug program.